Cart
sales@molnova.com
Evodenoson
CAS No. 844873-47-8
Evodenoson( —— )
Catalog No. M34593 CAS No. 844873-47-8
Evodenoson (ATL313) is a potent and selective adenosine A2a receptor (A2aR) agonist for the treatment of eye diseases, tumors, and immune system disorders, and may be used in studies of open-angle glaucoma and blood tumors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 599 | In Stock |
|
| 10MG | 903 | In Stock |
|
| 25MG | 1737 | In Stock |
|
| 50MG | 2288 | In Stock |
|
| 100MG | 3460 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEvodenoson
-
NoteResearch use only, not for human use.
-
Brief DescriptionEvodenoson (ATL313) is a potent and selective adenosine A2a receptor (A2aR) agonist for the treatment of eye diseases, tumors, and immune system disorders, and may be used in studies of open-angle glaucoma and blood tumors.
-
DescriptionEvodenoson (ATL313) is a potent and selective adenosine A2a receptor (A2aR) agonist for the treatment of eye diseases, tumors, and immune system disorders, and may be used in studies of open-angle glaucoma and blood tumors.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAdenosine Receptor
-
RecptorAdenosine Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number844873-47-8
-
Formula Weight499.52
-
Molecular FormulaC23H29N7O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO[C@H]1[C@H](N2C=3C(N=C2)=C(N)N=C(C#CCC4CCN(C(OC)=O)CC4)N3)O[C@H](C(NC5CC5)=O)[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
A2B receptor antagon...
A2B receptor antagonist 1 (EXAMPLE 9B) is a potent A2B adenosine receptor antagonist.
-
ISAM-140
ISAM-140 is a potent and highly selective antagonist of A2B adenosine receptor.
-
LUF6096
LUF6096 (CF-602) is a potent allosteric enhancer of the adenosine A3 receptor, exhibiting the capability to enhance agonist binding allosterically while demonstrating low orthosteric affinity across adenosine receptors.
